In today’s episode, we’ll be looking at considerations for Medical Affairs in Rare Disease and Gene Therapy
In this webinar, we will discover how Medical Affairs teams are evolving from an executional hub to a strategic pillar, resonating and reconciling the voice of the patient and clinicians, and driving insights to their organization.
In this webinar, a roundtable of experienced Medical Affairs leaders will discuss the opportunities and challenges evolving within their field, as well as the impact it can have on delivering great patient outcomes.
This article outlines the aspects of Medical Affairs strategy and launch excellence specific to supporting the development and launch of treatments targeting rare diseases, providing a roadmap for MA teams and organizations undertaking this planning.
In Q&A format, this article summarizes key learnings from a MAPS 2022 Global Annual Meeting panel presented by the Medical Strategy FAWG.
This webinar, a continuation from April 27, analyzes the future of Medical Affairs in Japan while discussing what we can do together to make Medical Affairs in Japan even more effective.
This white paper by the MAPS Executive Consortium synthesizes the views of senior global Medical Affairs leaders to provide a unified vision for the future of Medical Affairs in society, industry, teams and as individuals.
In this interview recorded at MAPS 2022 Global with Lobna Salem we discuss building a Medical Affairs department from the ground up.
What is Medical Affairs and what does it do in the biopharmaceutical and MedTech industries? Who works in Medical Affairs and what skills do you need to succeed? Find out in this essential guide to understanding, joining and thriving in Medical Affairs.
MAPS speaks with José Borbolla, Global Executive Medical Director at Esai, and Augusto Grinspan, VP Medical Affairs and Head LATAM with Merck KGaA about the evolution of Medical Affairs in Latin America.